Yaggan Mafirika Magane Joseph Leeuw is a South African medical doctor specializing in HIV/AIDS and tropical medicine. He has over 30 years of experience working in both public and private sectors in South Africa, the UK, Zambia, and Tanzania. His experience includes clinical research, managing HIV/AIDS clinics, training healthcare workers, and advising the South African government on HIV/AIDS policy and programs. He currently works as a training consultant, facilitating professional development courses on topics related to HIV/AIDS management.

1. PERSONAL DEATAILS
NAME: Yaggan Mafirika Magane Joseph LEEUW
CONTACT No: +27 72 271 2367
E-mail: 0722712367@vodamail.co.za; Skypeyaggan1
POSTAL ADDRESS: 43 Du Plessis Street, Akasia, Pretoria, 0118, South Africa.
DRIVERS LICENCE: CODE8
EDUCATIONAL BACKGROUND:
1993-1994: MEDICAL VIROLOGICAL PATHOLOGY, atMEDUNSA, (Deferred
completion of specialist programme)
1991: DIPLOMA INCLINICAL PATHOLOGY, Immunology, Microbiology,
Virology. RoyalPost-graduateMedical School, Hammersmith, University of
London; (Deferred examination in microbiology, credit in immunology module)
1989: MASTER OF SCIENCEINCLINICAL TROPICAL MEDICINE,
Schoolof Tropical Medicine and Hygiene, University of London.
1988: DIPLOMA INTROPICAL MEDICINEAND HYGIENE, RoyalCollege of
Physicians, London.
1977-1983: DOCTOROF MEDICINE, Crimea StateMedical Institute,
Simferopol, USSR. Main Clinical Syllabuses: InternalMedicine, Surgery,
Paediatrics, Obstetrics and Gynaecology, Infectious Diseases, Community
Medicine.
1976: CAMBRIDGESCHOOL LEAVING CERTIFICATE: Subjects Passed; Chemistry,
Biology, Human Biology, Physics, Mathematics, History, Geography, English.

2. WORK EXPERENCE:
2012- Current: Foundation for ProfessionalDevelopment
Position: Training Consultant
Responsibilities: Training Facilitator for professional and non-professional
health-care in the following areas/modules
 Immunology of HIV,
 Clinical Management of HIV, TB/MDR/XDR-TB, PMTCT, STI,
 NurseInitiation of HAART,
 Novel Technics in TB Diagnosis and their interpretation and
significance.
Part-time private practice focussing on the management of HIV
2005-2012: Bojanala DistrictNorth WestProvince
Position: ProjectManager/Principal Specialist
Responsibilities: TechnicalSupportwithin the District
 Develop, identify and implement a model for HIV Down-Referralfrom
hospitals to Primary Health Centres (PHCs) and Sub-DistrictHospitals
 Develop a tool to evaluate logistics, staffing and facility readiness of
PHCs for implementing the HIV Down-ReferralProgramme.
 Develop TB, MDR-TB, XDR-TB awareness and its relationship to and with
HIV, and the importance of contact tracing as a preventative and
curative strategy
 Promote the importance in implementing INH 6 month’s prophylaxis in
sputumnegative HIV infected patients and the importance of sputum
follow up after the initial 6 month prophylaxis in all HIV infected patients
 Co-ordination of training in HIV with stake-holders in addressing
challenges identified at the PHClevel.
 Ensurethe clinical supportof health-care personalat all levels in matters
related to HIV and its comprehensivemanagement, inclusiveof offering
testing all pregnantladies.

3.  Provideongoing training at maternity centres on fast-tracking PMTCT
amongstpregnant ladies and the importance of feeding methods in HIV
infected mothers.
 Provision of training for the nursing staff in the diagnosis, management
and referralof complicated HIV patients
 Cooperation with pharmacy in safeguarding stock out medication at
PHCs
Advisory roles
National Research Foundation (South Africa) – Health Sciences Adjudication
Panel
Member of the Data and Safety Monitoring Board - The Phidisa II Study Group
for ProjectPhidisa (Joint U.S.A, Departmentof Defence, NIAID, and SAMHS);
2004-2005: Provincial Headof HIV Comprehensive Implementation
Position: ProjectManager
Responsibilities: TechnicalSupportwithin the Province
 Identify hospitals within districts and the epidemiology of HIV with
urgent need to provide HIV services.
 Advice and makerecommendations on renovation of hospitals with
specific time framelinked to budget allocation.
 Account for expenditure of budget allocated to the CCMT programme
within the North West Province using the Division of Revenue Act
(DORA) monitoring tool.
 Supportvisits to hospital site for inspection of progress and challenges
 Report to Provincial Steering Committee of the North West Province
(PSC) on challenges identified during the site visit.
 Develop a recruitment strategy to attract health-care worker of all
categories to work within rural and underdeveloped areas (province).
 Coordinate with the laboratory services to ensureadequate provisioning
within specific time frames for a comprehensiveHIV programmein the
North WestProvince

4.  Advertiseposts to be filled with the firstintake of health-care staff to
‘track-lay’ the ComprehensiveHIV programme
 Providea coordinated training programmeon basic HIV for doctors and
nursing staff who will be the first ‘track-layers’ of thecomprehensiveHIV
programme
 Establish a phamacovigilanceprogrammewith the Medical University of
South Africa(MEDUNSA)
 Coordinate stakeholder meetings to ensure maximum support, buy-in
and ownership of the comprehensiveHIV programme
Technical and Advisory Roles:
1. Member of the National ComprehensiveCare Management and
Treatment Programme(CCMT); provideadvice in relation to challenges
and ensureachievements within the province in implementing the CCMT
programme, (National Department of Health- 2004-2012).
2. Coordinator of the CCMT programmewithin the provincehighlighting
progress and challenges with remedial action to be taken within specific
time frames, (Provincialand District Departmentof Health, North West
Government, 2004-2012).
3. Coordinator of accreditation for site readiness in the provision of HIV
services; invitation of national and multi-provincial teams on an
inspection readiness of hospitals, (Provincialand DistrictDepartment of
Health North West Government, 2004-2012).
4. Coordinate and advicepharmaceutical services on the various regimens
to be usein adult and children, HAART, and PMTCT; ensuring adequate
stock-in-hand as well as reservebased on weekly HIV new positivecases
and projected new cases, (Provincialand District Departmentof Health
North WestGovernment, 2004-2012)
5. Coordination of stakeholder meetings with NGOs such as Elizabeth
Glacier, Foundation for ProfessionalDevelopment (FPD), Reproductive
Health Research Unit (RHRU) and Broad-Reach within the North West
Province. Identification of common goals, challenges and achievement
of targets. (Provincialand District Department of Health North West
Government, 2004-2012)

5. 1997-1998: PrincipalClinical Investigator in the Global Adult Neviripine Clinical
Experimental Trial: (Boehringer Ingelheim PharmaceuticalCompany) within
South Africa
1994-tocurrent: Privatepracticemainly HIV related
1992-1994: MedicalUniversity of South Africa; Department of Virology, under
took post-graduatestudy in Clinical Virology and managed the HIV Clinic within
Ga-Rankuwa Hospital
1991-1992: Departmentof InternalMedicine. Established and managed the
HIV/AIDS Clinic at Teaching Hospital (MEDUNSA/Ga-Rankuwa Teaching
Hospital Complex)
1985-1987: University Teaching Hospital, Lusaka, Zambia; Matero Medical
Centre, Lusaka, Zambia
1983-1985: Internship atMuhimbili Medical Centre (University Teaching
Complex) Dar-es-Salaam, Tanzania
PUBLICATIONS:
1. Geographic distributionof infections causing liver diseases in Oxford
Textbook of Clinical Hepatology, (University of London, Master of
Science Dissertation 1989 London)
2. Symptomatology Spectrumof HIV infectedpatientsat Ga-Rankuwa
Hospital (1993, MEDUNSA)
3. The Status of Hepatitis B Viral Markers inBushmenat Schmidtsdrift,
South Africa. Base line Studies for Hepatitis B Immunisation. (1993,
MEDUSA)

6. 4. Comparisonof the Immunogenicity of Recombinant Hepatitis B
Vaccine from two different producers (1993-1994, MEDUNSA)
5. Mutations associatedwithLamivudine-resistance intherapy-naïve
hepatitis B virus (HBV) infectedpatients withandwithout HIVco-
infection:Implications for antiretroviral therapy inHBVand HIV co-
infectedSouthAfricanpatients. Journalof Medical Virology, 2007
November; 79 (11): 1650-1654. (2007 MEDUNSA)
REFERENCES:
1. Dr Zinhle Makatini, Consultant within the Departmentof Virology
MEDUNSA
Contact details Cell phone+27 82 955 0986; Office+27 12 521 4227
2. Dr Grace Makgoka; Foundation for ProfessionalDevelopment, Head of
Health Education and Training.
Contact details Cell phone+27 82 569 5164; office+27 12 816 9010
3. Dr Mmipe L. Modise, DistrictClinical Specialist, Joint Staff Wits
WITS University, Departmentof Family Medicine and Ekurhuleni District,
Gauteng.